Parafusiv (Paracetamol)

Paracetamol, the active ingredient in Parafusiv, is an aniline presented as a 500 mg tablet for oral use. It treats mild to moderate pain and reduces fever in adults and children. GNH USA supplies Parafusiv as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Parafusiv is marketed across the EU and conforms to European pharmacopeial standards, ensuring consistent quality for healthcare providers worldwide.

Parafusiv is an analgesic and antipyretic that acts on common pain‑related pathways and fever mechanisms. - Headache: provides relief of mild to moderate headache pain. - Musculoskeletal pain: reduces discomfort from strains, sprains and low‑back pain. - Fever: lowers elevated body temperature in febrile states. - Dental pain: eases pain associated with toothache or dental procedures. - Menstrual discomfort: helps alleviate menstrual‑related cramps and aches.

Parafusiv is generally well tolerated, but adverse reactions can occur.

Common Side Effects: - Nausea: mild stomach upset may be experienced. - Rash: occasional skin redness or itching. - Elevated liver enzymes: transient increase detected in blood tests.

Serious or Rare Side Effects: - Hepatotoxicity: risk of liver injury with overdose or chronic high‑dose use. - Stevens‑Johnson syndrome: rare severe skin reaction. - Anaphylaxis: extremely rare allergic response requiring immediate medical attention. - Blood disorders: rare cases of thrombocytopenia or neutropenia reported.

Parafusiv should be used with attention to individual health status and potential drug interactions. - Liver disease: avoid or limit use; monitor liver function. - Alcohol consumption: limit intake as it may increase hepatotoxic risk. - Pregnancy: consult a healthcare professional before use. - Children: dosage must be prescribed based on weight and age. - Renal impairment: use with caution and under medical guidance. - Store below 25°C: keep in the original packaging, protect from moisture and direct sunlight.

Parafusiv may interact with several medicines, altering its efficacy or safety profile.

Major Interactions (Avoid): - Warfarin: may enhance anticoagulant effect, increasing bleeding risk. - Isoniazid: combined use can raise risk of liver toxicity.

Moderate Interactions (Monitor Closely): - Antiepileptics (e.g., carbamazepine, phenytoin): may reduce analgesic effect. - Oral contraceptives: may slightly decrease plasma concentration of paracetamol. - Rifampicin: may increase metabolic clearance, lowering therapeutic levels. - Lithium: concurrent use can affect lithium serum concentrations. - CYP450 inducers: substances that induce CYP enzymes may reduce drug exposure.